Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug

Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.